The Artificial Intelligence in Genomics Market Size is valued at 513.68 Million in 2022 and is predicted to reach 18618.72 Million by the year 2031 at a 49.2 % CAGR during the forecast period for 2023-2031.
Market Segmentation
The Global Artificial Intelligence in Genomics market is segmented on the basis of offering, application, technology type, functionality, and region. Based on the offering, the AI in the genomics market is divided into Software, Services. Based on the application, the AI in the genomics market is divided into Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & animal Research, Other Applications. On the basis of technology, the market is segmented into Machine Learning and Other Technologies. Machine Learning is further segmented into Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning, Other Machine Learning Technologies.
The growing research and development activities for the development of advanced treatment to treat various diseases and the high application of machine learning and deep learning in drug development are expected to the market growth significantly in the coming years. By Functionality, the market is segmented into Genome Sequencing, Gene Editing, Clinical Workflows, and Predictive Genetic Testing & Preventive Medicine. By end-user, the market is segmented into Pharmaceutical & Biotech Companies, Healthcare Providers, Research Centers, Academic Institutes & Government Organizations, and Other End-Users. The growing adoption of AI in the large number of companies operating in drug development and research activities is expected to propel the growth AI in the genomics market significantly.
Based on the region, the market is segmented into Latin America, Asia Pacific, Middle East & Africa, North America, and Europe. In 2019, North America accounted for the largest share in AI in the genomics market, followed by Europe.
Competitive Landscape
Some Of The Key Players In The Artificial Intelligence in Genomics Market:
- AI Therapeutics, Inc.,
- Ares Genetics GmbH,
- BenevolentAI,
- BioSymetrics,
- Cambridge Cancer Genomics (UK),
- Clover Therapeutics,
- Congenica Ltd,
- Coral Genomics,
- CureMatch, Inc.,
- Cyclica Inc.,
- Data4Cure, Inc,
- Deep Genomics,
- Desktop Genetics Ltd.,
- Diploid (Belgium),
- DNAnexus,
- Emedgene,
- Empiric Logic,
- Engine Biosciences Pte. Ltd.,
- Fabric Genomics, Inc.,
- FDNA Inc. (US),
- Freenome Holdings, Inc.,
- Genoox, Ltd.,
- IBM (US),
- LifebitAI,
- Microsoft (Project Hanover),
- MolecularMatch Inc. (US),
- NVIDIA Corporation (US),
- PrecisionLife Ltd,
- Predictive Oncology,
- SOPHiA GENETICS, Inc.,
- Trace Genomics,
- Verge Genomics,
- WhiteLab Genomics,
- WuXi Nextcode Genomics
The Artificial Intelligence in Genomics Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 513.68 Million |
|
Revenue Forecast In 2031 |
USD 18618.72 Million |
|
Growth Rate CAGR |
CAGR of 49.2 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Offering, By Functionality, By Technology, By Application, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
AI Therapeutics, Inc., Ares Genetics GmbH, BenevolentAI, BioSymetrics, Cambridge Cancer Genomics (UK), Clover Therapeutics, Congenica Ltd, Coral Genomics, CureMatch, Inc., Cyclica Inc., Data4Cure, Inc, Deep Genomics, Desktop Genetics Ltd., Diploid (Belgium), DNAnexus, Emedgene, Empiric Logic, Engine Biosciences Pte. Ltd., Fabric Genomics, Inc., FDNA Inc. (US), Freenome Holdings, Inc., Genoox, Ltd., IBM (US), LifebitAI, Microsoft (Project Hanover), MolecularMatch Inc. (US), NVIDIA Corporation (US), PrecisionLife Ltd, Predictive Oncology, SOPHiA GENETICS, Inc., Trace Genomics, Verge Genomics, WhiteLab Genomics, WuXi Nextcode Genomics |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
